We are live on ! Find out more
A

AJOVista Portfolio holdings

AUM $23.4M
1-Year Est. Return 76.18%
This Fund
S&P 500
This Quarter Est. Return
+29.83%
1 Year Est. Return
+76.18%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$23.4M
AUM Growth
-$11.3M
Cap. Flow
-$13.9M
Cap. Flow %
-59.37%
Top 10 Hldgs %
39.09%
Holding
175
New
100
Increased
8
Reduced
3
Closed
63

Top Buys

1
BEKE icon
KE Holdings
BEKE
+$1.56M
2
QFIN icon
Qfin Holdings
QFIN
+$1.24M
3
JD icon
JD.com
JD
+$852K
4
BABA icon
Alibaba
BABA
+$723K
5
VALE icon
Vale
VALE
+$325K

Sector Composition

1 Consumer Discretionary 20.05%
2 Healthcare 18.93%
3 Financials 12.06%
4 Materials 9.82%
5 Real Estate 9.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LINC icon
26
Lincoln Educational Services
LINC
$1.36B
$233K 0.99%
+19,481
New +$242K
SWIM icon
27
Latham Group
SWIM
$692M
$228K 0.97%
+33,493
New +$163K
CRAI icon
28
CRA International
CRAI
$1.11B
$217K 0.93%
+1,240
New +$207K
CDNA icon
29
CareDx
CDNA
$2.05B
$215K 0.92%
+6,880
New +$171K
PMTS icon
30
CPI Card Group
PMTS
$216M
$215K 0.92%
+7,709
New +$212K
EGRX
31
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$211K 0.9%
56,438
+45,206
+402% +$216K
ARIS
32
DELISTED
Aris Water Solutions
ARIS
$210K 0.9%
+12,423
New +$201K
TARS icon
33
Tarsus Pharmaceuticals
TARS
$2.61B
$207K 0.89%
+6,305
New +$177K
BBSI icon
34
Barrett Business Services
BBSI
$984M
$202K 0.86%
+5,376
New +$189K
VRDN icon
35
Viridian Therapeutics
VRDN
$1.99B
$201K 0.86%
+8,817
New +$144K
TILE icon
36
Interface
TILE
$1.92B
$200K 0.85%
+10,529
New +$182K
SNCR
37
DELISTED
Synchronoss Technologies
SNCR
$192K 0.82%
+12,917
New +$151K
UTI icon
38
Universal Technical Institute
UTI
$2.22B
$188K 0.81%
+11,589
New +$199K
PINE
39
Alpine Income Property Trust
PINE
$359M
$184K 0.78%
+10,085
New +$176K
WRBY icon
40
Warby Parker
WRBY
$3.24B
$181K 0.77%
+11,103
New +$167K
OOMA icon
41
Ooma
OOMA
$568M
$178K 0.76%
+15,665
New +$155K
SLRN
42
DELISTED
ACELYRIN
SLRN
$173K 0.74%
+35,084
New +$181K
MIR icon
43
Mirion Technologies
MIR
$3.91B
$173K 0.74%
+15,623
New +$164K
XFOR icon
44
X4 Pharmaceuticals
XFOR
$360M
$172K 0.74%
+8,588
New +$179K
INOD icon
45
Innodata
INOD
$1.99B
$172K 0.74%
+10,278
New +$173K
ALTO icon
46
Alto Ingredients
ALTO
$453M
$171K 0.73%
+106,049
New +$160K
COOK icon
47
Traeger
COOK
$192M
$170K 0.73%
+925
New +$137K
CRNC icon
48
Cerence
CRNC
$390M
$170K 0.73%
+53,968
New +$159K
LYTS icon
49
LSI Industries
LYTS
$879M
$168K 0.72%
+10,406
New +$159K
RGP icon
50
Resources Connection
RGP
$159M
$166K 0.71%
+17,068
New +$176K

Similar funds

AJOVista's Q3 2024 Portfolio in Review

As of Q3 2024, AJOVista held 175 positions worth $23.4M, down 33% from $34.7M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

AJOVista withdrew a net $13.9M in Q3 2024, closing 63 positions and reducing 3 holdings. Its most notable exit was Apple, an estimated $2.32M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 20% of assets, up from 9.4% a quarter earlier, followed by Healthcare and Financials.

Against the trend, AJOVista opened a new position in KE Holdings worth $2.1M.

  • AJOVista's largest Q3 2024 buy was KE Holdings: 105,472 shares worth $2.1M.
  • AJOVista added most to Eagle Pharmaceuticals, Inc. in Q3 2024, an estimated $216K increase.
  • AJOVista's biggest Q3 2024 reduction was iShares MSCI Saudi Arabia ETF, cutting an estimated $6.05M.
  • AJOVista fully exited Apple in Q3 2024, selling an estimated $2.32M.
  • AJOVista's ten largest holdings make up 39% of its $23.4M portfolio in Q3 2024.
  • AJOVista opened 100 new positions and closed 63 in Q3 2024.
  • AJOVista's portfolio value fell 33% quarter-over-quarter to $23.4M.

Based on AJOVista's 13F filing for Q3 2024, filed 12 Nov 2024.